Male breast growth is driven by shifting the balance between testosterone and estrogen in the body. Testosterone keeps breast tissue small, while estrogen stimulates it to grow. Even a slight shift in that ratio can trigger glandular development. Whether breast growth happens through medical hormone therapy, medications, or underlying health changes, the biological mechanism is the same.
The path you take depends on your goals. For transgender women and nonbinary people seeking feminization, supervised hormone therapy is the most effective and well-studied approach. For others, understanding what causes male breast tissue to develop (and what doesn’t) can help you make informed choices.
How Male Breast Growth Works
Everyone produces both testosterone and estrogen regardless of sex. In people assigned male at birth, testosterone is dominant, which suppresses breast tissue from developing beyond a small amount of glandular tissue behind the nipple. When estrogen levels rise relative to testosterone, that glandular tissue begins to proliferate, forming breast buds and eventually more visible breast mounds.
This is the same process that occurs during female puberty, just triggered later and under different circumstances. The clinical term for male breast growth is gynecomastia, and it’s distinct from pseudogynecomastia, which is simply fat accumulation in the chest without any glandular development underneath. Gynecomastia feels like a firm, rubbery disc of tissue beneath the nipple. Pseudogynecomastia feels soft throughout, with no distinct mass.
Feminizing Hormone Therapy
The most reliable way to develop breasts as a male-bodied person is feminizing hormone therapy, prescribed and monitored by a healthcare provider experienced in gender-affirming care. This is the standard treatment for transgender women and is backed by decades of clinical data.
The primary hormone used is estradiol, a form of estrogen. It can be delivered as an oral tablet, a transdermal patch applied to the skin, or an injection. Many treatment plans also include an anti-androgen, a medication that blocks testosterone’s effects, allowing estrogen to work more effectively on breast tissue. Spironolactone is among the most commonly prescribed anti-androgens for this purpose.
Providers typically start at a lower dose and increase gradually based on blood work and how your body responds. The goal is to bring estrogen levels into the typical female range while reducing testosterone. Higher doses don’t necessarily produce faster or larger growth. The process is individualized, and genetics play a significant role in how much breast tissue ultimately develops, just as they do for cisgender women.
What the Timeline Looks Like
Breast budding, a small tender lump beneath each nipple, typically begins 3 to 6 months after starting hormone therapy. Growth continues gradually from there, with maximum development reached after 2 to 3 years. Most transgender women on hormone therapy develop breasts in the A to B cup range, though results vary widely. Some develop more, some less. The tissue that grows is permanent glandular breast tissue, meaning it won’t disappear if hormones are stopped, though it may soften or shrink somewhat.
Soreness and nipple sensitivity are normal during active growth phases. Uneven development is also common, especially early on, and usually evens out over time.
Medications That Can Trigger Growth
Medications account for an estimated 10 to 25 percent of all gynecomastia cases. They cause breast development through several mechanisms: raising estrogen levels, lowering testosterone, blocking androgen receptors, or increasing prolactin (a hormone involved in breast tissue development).
Drugs with the strongest evidence for causing male breast growth include:
- Anti-androgens like spironolactone, flutamide, bicalutamide, and cyproterone, often prescribed for prostate conditions or as part of feminizing therapy
- 5-alpha reductase inhibitors like finasteride and dutasteride, commonly used for hair loss and enlarged prostate
- Estrogen-containing medications taken directly
- Certain antipsychotics like risperidone, which raise prolactin levels
- Opioids, which can suppress testosterone production over time
- Some heart medications like spironolactone (also used as a diuretic), nifedipine, and verapamil
These medications are not prescribed for the purpose of breast growth on their own (outside of gender-affirming care). The breast development they cause is a side effect, and the amount of growth is unpredictable and often modest.
Do Supplements or Phytoestrogens Work?
The short answer is no, not in any meaningful way. Despite widespread claims online about soy, fenugreek, Pueraria mirifica, and other plant-based estrogen sources, the scientific evidence does not support their ability to cause breast growth in humans.
Phytoestrogens are plant compounds that weakly mimic estrogen in the body. A 2021 review of 38 clinical trials found no evidence that soy or its active compounds (isoflavones) affected testosterone or estrogen levels in males. A separate 2018 study had college-aged men take soy protein supplements for 12 weeks while doing resistance training. Soy had no effect on their testosterone levels. Even infants fed soy formula from birth showed no differences in testosterone compared to those fed cow’s milk formula or breast milk over 28 weeks.
The studies that do show feminizing effects from phytoestrogens typically involve extremely high doses given to rats or other animals, not humans consuming normal or even large amounts. Herbal supplements marketed for breast growth are not regulated for efficacy, and many contain unknown or inconsistent amounts of active ingredients.
Gynecomastia Grading
Clinicians classify the extent of male breast growth using a four-point scale:
- Grade 1: Minor enlargement, no excess skin
- Grade 2a: Moderate enlargement, no excess skin
- Grade 2b: Moderate enlargement with some excess skin
- Grade 3: Marked enlargement with excess skin
This grading matters mainly if you’re considering surgical options. Grade 1 and 2a can often be addressed with liposuction if reduction is desired, while grades 2b and 3 typically require excisional surgery. For those seeking growth rather than reduction, the grading system gives you a framework for understanding where your development falls.
Health Considerations
Male breast tissue, whether naturally occurring or hormone-induced, carries some health considerations worth knowing about. A large National Cancer Institute study found that gynecomastia is associated with a 10-fold increased risk of breast cancer in men, independent of obesity. That sounds alarming, but context matters: male breast cancer is extremely rare to begin with, affecting roughly 1 in 100,000 men per year. A 10-fold increase on a very small baseline number is still a small absolute risk.
For those on feminizing hormone therapy, regular monitoring of blood work is standard practice. Estrogen therapy can affect cholesterol, blood clotting risk, and liver function. Smoking significantly increases the risk of blood clots when combined with estrogen, so quitting is strongly recommended before or during treatment.
If you’re experiencing unexpected breast growth without intentionally taking hormones or medications, it’s worth getting evaluated. Unintentional gynecomastia can signal liver disease, kidney problems, thyroid dysfunction, or in rare cases, hormone-producing tumors. A blood panel checking testosterone, estrogen, liver function, and thyroid hormones is the standard first step.